SLAMF7-directed Immunostimulatory Antibody [EPC]

SLAMF7-directed Immunostimulatory Antibody [EPC] was reported 5171 times

Drugs of the SLAMF7-directed Immunostimulatory Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PARAINFLUENZAE VIRAL LARYNGOTRACHEOBRONCHITIS 2 0.6667
1 HUMAN METAPNEUMOVIRUS TEST 3 0.5000
2 ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION 3 0.1000
3 ANTIVIRAL PROPHYLAXIS 1 0.0909
4 BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0 2 0.0769
5 FACTOR VII DEFICIENCY 5 0.0746
6 RESPIROVIRUS TEST POSITIVE 5 0.0735
7 BENCE JONES PROTEIN URINE PRESENT 1 0.0357
8 PARAPROTEINAEMIA 11 0.0355
9 PLASMA CELL MYELOMA REFRACTORY 47 0.0351
10 LIGHT CHAIN ANALYSIS DECREASED 2 0.0290
11 MENINGITIS STREPTOCOCCAL 4 0.0274
12 FEBRILE INFECTION 27 0.0229
13 GASTROINTESTINAL CANCER METASTATIC 4 0.0221
14 PLASMA CELL LEUKAEMIA 13 0.0217
15 AEROMONAS INFECTION 4 0.0212
16 TOXIC SHOCK SYNDROME STREPTOCOCCAL 4 0.0207
17 CAMPYLOBACTER GASTROENTERITIS 12 0.0202
18 PNEUMOCOCCAL SEPSIS 13 0.0198
19 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 2 0.0196
20 LARYNGEAL SQUAMOUS CELL CARCINOMA 2 0.0185
21 COLORECTAL ADENOCARCINOMA 4 0.0179
22 PNEUMONIA PARAINFLUENZAE VIRAL 3 0.0176
23 BILE DUCT ADENOCARCINOMA 1 0.0167
24 AURAL POLYP 1 0.0152
25 PLASMA CELL MYELOMA 576 0.0147
26 INFLUENZA A VIRUS TEST POSITIVE 6 0.0139
27 PARAGANGLION NEOPLASM 2 0.0137
28 MENINGITIS PNEUMOCOCCAL 5 0.0137
29 ATYPICAL FIBROXANTHOMA 1 0.0133
30 PLASMA CELL MYELOMA RECURRENT 40 0.0123
31 MONOCLONAL IMMUNOGLOBULIN PRESENT 9 0.0118
32 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 2 0.0115
33 HUMAN POLYOMAVIRUS INFECTION 6 0.0113
34 RECTAL PERFORATION 6 0.0111
35 TOXIC SHOCK SYNDROME 7 0.0111
36 VISCERAL LEISHMANIASIS 8 0.0111
37 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 9 0.0107
38 PENILE INFECTION 2 0.0103
39 LYMPHOMATOID PAPULOSIS 3 0.0102
40 ASYMPTOMATIC COVID-19 4 0.0102
41 PNEUMONIA MYCOPLASMAL 8 0.0101
42 LIGHT CHAIN ANALYSIS ABNORMAL 2 0.0096
43 PNEUMONIA PNEUMOCOCCAL 14 0.0094
44 LISTERIOSIS 10 0.0090
45 SQUAMOUS CELL CARCINOMA OF THE CERVIX 2 0.0090
46 KERATOPATHY 14 0.0088
47 LIGHT CHAIN ANALYSIS INCREASED 9 0.0087
48 CATARACT SUBCAPSULAR 5 0.0082
49 PRIMARY AMYLOIDOSIS 2 0.0078
50 BETA 2 MICROGLOBULIN INCREASED 2 0.0077
51 METAPNEUMOVIRUS INFECTION 6 0.0077
52 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 6 0.0076
53 HYPERPROTEINAEMIA 2 0.0076
54 ASPIRATION BONE MARROW 1 0.0075
55 HERPES ZOSTER DISSEMINATED 6 0.0075
56 HYPERCALCAEMIA OF MALIGNANCY 2 0.0074
57 CYTOMEGALOVIRUS INFECTION REACTIVATION 32 0.0072
58 MONOCLONAL IMMUNOGLOBULIN INCREASED 2 0.0070
59 HYPERVISCOSITY SYNDROME 2 0.0069
60 LEISHMANIASIS 2 0.0069
61 MORGANELLA INFECTION 2 0.0068
62 PNEUMONIA INFLUENZAL 8 0.0067
63 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
64 BILIARY SEPSIS 3 0.0065
65 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 8 0.0063
66 BLINDNESS CORTICAL 3 0.0061
67 FULL BLOOD COUNT INCREASED 7 0.0059
68 INFECTIOUS COLITIS 3 0.0057
69 ANOGENITAL WARTS 5 0.0056
70 EOSINOPHILIC COLITIS 2 0.0055
71 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 2 0.0054
72 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
73 THALAMIC INFARCTION 3 0.0051
74 RECTAL ADENOCARCINOMA 3 0.0050
75 ARTHROSCOPIC SURGERY 1 0.0050
76 STRONGYLOIDIASIS 8 0.0049
77 HYPOPHOSPHATAEMIA 36 0.0049
78 PLASMACYTOMA 9 0.0048
79 ABDOMINAL WALL ABSCESS 3 0.0046
80 CARDIAC AMYLOIDOSIS 5 0.0045
81 METASTASES TO PANCREAS 2 0.0045
82 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
83 HEAT ILLNESS 3 0.0044
84 ANGIOSARCOMA 2 0.0043
85 NEUTROPENIC INFECTION 4 0.0042
86 ORTHOSTATIC INTOLERANCE 3 0.0042
87 B-CELL TYPE ACUTE LEUKAEMIA 3 0.0041
88 RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0040
89 MENINGITIS LISTERIA 2 0.0039
90 BONE LESION 14 0.0039
91 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
92 SQUAMOUS CELL CARCINOMA OF SKIN 23 0.0038
93 HEPATITIS E 6 0.0038
94 ATRIAL ENLARGEMENT 1 0.0037
95 PULMONARY NOCARDIOSIS 3 0.0036
96 PAPILLOMA VIRAL INFECTION 6 0.0036
97 CAMPYLOBACTER INFECTION 3 0.0036
98 LYMPHOCYTE COUNT ABNORMAL 4 0.0036
99 INTENTION TREMOR 2 0.0035
100 ESCHERICHIA SEPSIS 10 0.0034
101 PULMONARY SEPSIS 5 0.0034
102 POLYARTERITIS NODOSA 2 0.0034
103 OSTEOLYSIS 7 0.0034
104 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6 0.0034
105 PARVOVIRUS B19 INFECTION 3 0.0034
106 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
107 GINGIVAL HYPERTROPHY 5 0.0033
108 BLOOD IMMUNOGLOBULIN M INCREASED 2 0.0033
109 PNEUMONIA PSEUDOMONAL 5 0.0033
110 OTOTOXICITY 6 0.0032
111 JC VIRUS INFECTION 5 0.0031
112 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
113 PLATELET TRANSFUSION 4 0.0031
114 MASTOIDITIS 3 0.0031
115 POSTOPERATIVE ABSCESS 2 0.0030
116 KERATOACANTHOMA 2 0.0029
117 CYTOPENIA 35 0.0029
118 PERIPHERAL ARTERY OCCLUSION 4 0.0028
119 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
120 PRODUCT PREPARATION ISSUE 18 0.0027
121 LOBAR PNEUMONIA 5 0.0027
122 ACETABULUM FRACTURE 1 0.0027
123 SOFT TISSUE INJURY 2 0.0026
124 PROTEIN TOTAL INCREASED 7 0.0026
125 HEPATIC MASS 5 0.0026
126 ADMINISTRATION SITE REACTION 1 0.0026
127 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
128 EPIDIDYMITIS 3 0.0026
129 SUPERINFECTION BACTERIAL 2 0.0025
130 OESOPHAGEAL CANDIDIASIS 10 0.0025
131 EROSIVE DUODENITIS 2 0.0025
132 BRONCHIAL HYPERREACTIVITY 3 0.0025
133 PNEUMOCYSTIS JIROVECII PNEUMONIA 25 0.0025
134 MALIGNANT NEOPLASM PROGRESSION 254 0.0025
135 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
136 EXTRAVASATION 10 0.0024
137 HELICOBACTER GASTRITIS 3 0.0024
138 SYSTEMIC INFECTION 4 0.0024
139 GASTROENTERITIS SALMONELLA 2 0.0024
140 BACTERAEMIA 28 0.0024
141 GINGIVAL ERYTHEMA 2 0.0023
142 AXONAL NEUROPATHY 2 0.0023
143 LIP INJURY 3 0.0023
144 FOREIGN BODY IN RESPIRATORY TRACT 3 0.0023
145 MENINGITIS CRYPTOCOCCAL 4 0.0023
146 PSEUDOMONAL SEPSIS 4 0.0023
147 LYMPHOCYTE COUNT DECREASED 40 0.0023
148 CYTOMEGALOVIRUS INFECTION 37 0.0022
149 BIOPSY BONE MARROW ABNORMAL 1 0.0022
150 IMMUNOGLOBULINS DECREASED 3 0.0022
151 SOFT TISSUE INFECTION 4 0.0022
152 PUNCTATE KERATITIS 2 0.0022
153 BONE CYST 2 0.0021
154 ESCHERICHIA BACTERAEMIA 5 0.0021
155 PNEUMONIA CRYPTOCOCCAL 2 0.0021
156 POST HERPETIC NEURALGIA 3 0.0021
157 CYTOKINE RELEASE SYNDROME 41 0.0020
158 SUBCUTANEOUS EMPHYSEMA 2 0.0020
159 COVID-19 PNEUMONIA 24 0.0020
160 DEVICE RELATED THROMBOSIS 2 0.0020
161 PNEUMONIA FUNGAL 8 0.0020
162 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
163 ATYPICAL PNEUMONIA 6 0.0020
164 LUNG ADENOCARCINOMA 6 0.0020
165 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
166 DIVERTICULAR PERFORATION 4 0.0019
167 CORONAVIRUS TEST POSITIVE 2 0.0019
168 BLOOD PHOSPHORUS DECREASED 7 0.0019
169 ENTEROCOLITIS 11 0.0019
170 HEPATITIS B REACTIVATION 6 0.0019
171 PNEUMONIA VIRAL 6 0.0019
172 HYPERCALCAEMIA 23 0.0019
173 HYPOGAMMAGLOBULINAEMIA 12 0.0018
174 MENINGITIS 12 0.0018
175 VEIN RUPTURE 3 0.0018
176 SALMONELLOSIS 3 0.0018
177 INFECTION REACTIVATION 2 0.0017
178 AMYLOIDOSIS 3 0.0017
179 THERAPY PARTIAL RESPONDER 27 0.0017
180 MYELODYSPLASTIC SYNDROME 25 0.0017
181 HYPOPITUITARISM 3 0.0017
182 BILE DUCT CANCER 2 0.0017
183 COLON OPERATION 2 0.0017
184 BASAL CELL CARCINOMA 26 0.0017
185 SECONDARY IMMUNODEFICIENCY 2 0.0016
186 SINUS NODE DYSFUNCTION 3 0.0016
187 FULL BLOOD COUNT DECREASED 33 0.0016
188 ATRIAL FLUTTER 13 0.0016
189 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
190 NEUTROPHIL COUNT DECREASED 66 0.0016
191 MALIGNANT MELANOMA IN SITU 2 0.0016
192 ACUTE MYELOID LEUKAEMIA 25 0.0016
193 ADENOCARCINOMA OF COLON 3 0.0016
194 HYPOPROTEINAEMIA 3 0.0016
195 ILEOSTOMY 4 0.0016
196 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
197 PYELONEPHRITIS ACUTE 3 0.0015
198 OBLITERATIVE BRONCHIOLITIS 2 0.0015
199 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
200 COMPRESSION FRACTURE 8 0.0015
201 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
202 SIALOADENITIS 2 0.0015
203 CLUMSINESS 4 0.0015
204 AUTOIMMUNE HAEMOLYTIC ANAEMIA 5 0.0015
205 CERVICAL VERTEBRAL FRACTURE 5 0.0014
206 ANGULAR CHEILITIS 1 0.0014
207 FEBRILE NEUTROPENIA 95 0.0014
208 PERIODONTAL DISEASE 2 0.0014
209 NEUTROPENIA 194 0.0014
210 H1N1 INFLUENZA 2 0.0014
211 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
212 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
213 NEUROGENIC BLADDER 3 0.0014
214 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
215 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
216 BLOOD ELECTROLYTES DECREASED 2 0.0014
217 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
218 JAW FRACTURE 3 0.0014
219 KLEBSIELLA INFECTION 7 0.0014
220 PATHOLOGICAL FRACTURE 7 0.0014
221 TUMOUR LYSIS SYNDROME 12 0.0014
222 CORONAVIRUS INFECTION 9 0.0014
223 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
224 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
225 FAILURE TO THRIVE 7 0.0013
226 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
227 PROTEIN TOTAL DECREASED 5 0.0013
228 CEREBROVASCULAR DISORDER 4 0.0013
229 EMBOLISM VENOUS 4 0.0013
230 SEPTIC SHOCK 57 0.0013
231 METASTATIC MALIGNANT MELANOMA 3 0.0013
232 THROMBOCYTOPENIA 146 0.0013
233 PROSTATE CANCER STAGE II 4 0.0013
234 NEOPLASM SKIN 2 0.0013
235 RHINOVIRUS INFECTION 5 0.0013
236 SPINAL CORD COMPRESSION 5 0.0013
237 ONYCHOLYSIS 2 0.0013
238 LYMPHOPENIA 18 0.0013
239 FUNGAEMIA 2 0.0013
240 PLATELET COUNT DECREASED 134 0.0013
241 NIGHT BLINDNESS 2 0.0012
242 AORTIC VALVE DISEASE 2 0.0012
243 COSTOCHONDRITIS 2 0.0012
244 ESCHERICHIA INFECTION 10 0.0012
245 SPINAL STENOSIS 5 0.0012
246 SPINAL COMPRESSION FRACTURE 10 0.0012
247 NEUROPATHY PERIPHERAL 115 0.0012
248 EMBOLISM 10 0.0012
249 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
250 UROSEPSIS 11 0.0012
251 URINARY TRACT INFECTION BACTERIAL 3 0.0012
252 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
253 CANCER PAIN 3 0.0012
254 ACUTE SINUSITIS 2 0.0012
255 TREATMENT DELAYED 2 0.0012
256 SPLENIC INFARCTION 2 0.0011
257 ACUTE RESPIRATORY FAILURE 22 0.0011
258 PNEUMONITIS 31 0.0011
259 PARAPARESIS 2 0.0011
260 MALIGNANT MELANOMA 15 0.0011
261 SEPSIS 124 0.0011
262 HYPOCALCAEMIA 21 0.0011
263 OPHTHALMIC HERPES ZOSTER 2 0.0011
264 IMMUNE THROMBOCYTOPENIA 5 0.0011
265 LABORATORY TEST ABNORMAL 32 0.0011
266 ADENOCARCINOMA GASTRIC 1 0.0011
267 LEUKOENCEPHALOPATHY 4 0.0011
268 SQUAMOUS CELL CARCINOMA 10 0.0011
269 SKIN TOXICITY 6 0.0011
270 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
271 NON-SMALL CELL LUNG CANCER 5 0.0010
272 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
273 HYPOALBUMINAEMIA 8 0.0010
274 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
275 CELL DEATH 2 0.0010
276 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 5 0.0010
277 METABOLIC ENCEPHALOPATHY 3 0.0010
278 DEVICE RELATED SEPSIS 2 0.0010
279 AUTONOMIC NEUROPATHY 1 0.0010
280 PANCYTOPENIA 55 0.0010
281 NEUTROPENIC SEPSIS 7 0.0010
282 FEMORAL NECK FRACTURE 5 0.0010
283 PRODUCT PREPARATION ERROR 20 0.0010
284 CHEST INJURY 2 0.0010
285 LUNG INFECTION 15 0.0010
286 AXILLARY MASS 1 0.0010
287 GASTROINTESTINAL PERFORATION 4 0.0010
288 SUBILEUS 2 0.0010
289 MALABSORPTION 5 0.0010
290 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
291 ELECTROLYTE IMBALANCE 11 0.0009
292 BILE DUCT STONE 3 0.0009
293 PNEUMONIA 304 0.0009
294 INFUSION RELATED REACTION 62 0.0009
295 BACTERIAL SEPSIS 3 0.0009
296 CORNEAL DISORDER 2 0.0009
297 LISTLESS 3 0.0009
298 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
299 ANAEMIA 173 0.0009
300 WHITE BLOOD CELL COUNT DECREASED 98 0.0009
301 CARDIAC FAILURE ACUTE 6 0.0009
302 DEEP VEIN THROMBOSIS 57 0.0009
303 PUSTULAR PSORIASIS 3 0.0009
304 LUMBAR VERTEBRAL FRACTURE 4 0.0009
305 COLON CANCER 13 0.0009
306 CYTOMEGALOVIRUS COLITIS 2 0.0009
307 CAROTID ARTERY STENOSIS 3 0.0009
308 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
309 SUDDEN DEATH 9 0.0008
310 JAUNDICE CHOLESTATIC 3 0.0008
311 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
312 URINARY TRACT OBSTRUCTION 2 0.0008
313 PLEURISY 5 0.0008
314 CHOLECYSTITIS 10 0.0008
315 VARICELLA 2 0.0008
316 LACUNAR INFARCTION 2 0.0008
317 GUILLAIN-BARRE SYNDROME 4 0.0008
318 INGUINAL HERNIA 5 0.0008
319 MOUTH HAEMORRHAGE 6 0.0008
320 ATRIAL FIBRILLATION 79 0.0008
321 ORGANISING PNEUMONIA 4 0.0008
322 CARDIAC DYSFUNCTION 3 0.0008
323 STEM CELL TRANSPLANT 2 0.0008
324 IMMUNOSUPPRESSION 7 0.0008
325 FRACTURE 15 0.0008
326 TOXIC ENCEPHALOPATHY 4 0.0008
327 PHLEBITIS 4 0.0008
328 SKIN REACTION 11 0.0008
329 ACTINIC KERATOSIS 2 0.0008
330 ASPERGILLOSIS 1 0.0008
331 MUCOSAL INFLAMMATION 20 0.0008
332 ASPERGILLUS INFECTION 5 0.0008
333 RETINAL DETACHMENT 7 0.0008
334 THERAPY NON-RESPONDER 34 0.0008
335 POLYNEUROPATHY 9 0.0008
336 AZOTAEMIA 3 0.0008
337 ANAL FISTULA 4 0.0007
338 ANION GAP INCREASED 1 0.0007
339 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
340 BRONCHIECTASIS 5 0.0007
341 COLITIS ISCHAEMIC 5 0.0007
342 ILEUS 9 0.0007
343 LEUKOPENIA 36 0.0007
344 PULMONARY EMBOLISM 68 0.0007
345 DEVICE RELATED INFECTION 11 0.0007
346 ALVEOLITIS 1 0.0007
347 PULMONARY TOXICITY 5 0.0007
348 CHOLECYSTITIS ACUTE 4 0.0007
349 ADVERSE EVENT 65 0.0007
350 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
351 PANCREATIC CARCINOMA METASTATIC 2 0.0007
352 METASTASIS 5 0.0007
353 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
354 OSTEONECROSIS OF JAW 17 0.0007
355 MELANOCYTIC NAEVUS 3 0.0007
356 STRIDOR 2 0.0007
357 FEMUR FRACTURE 21 0.0007
358 THORACIC VERTEBRAL FRACTURE 2 0.0007
359 ILEUS PARALYTIC 3 0.0007
360 TRANSFUSION 7 0.0007
361 IRON DEFICIENCY 3 0.0007
362 MYELOSUPPRESSION 24 0.0007
363 BONE MARROW DISORDER 2 0.0007
364 CRANIOCEREBRAL INJURY 2 0.0007
365 PROSTATITIS 2 0.0007
366 CELLULITIS 33 0.0007
367 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
368 MASTICATION DISORDER 2 0.0007
369 CHRONIC MYELOID LEUKAEMIA 3 0.0006
370 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
371 DIASTOLIC DYSFUNCTION 2 0.0006
372 DISEASE PROGRESSION 76 0.0006
373 PELVIC FRACTURE 5 0.0006
374 PYREXIA 221 0.0006
375 NON-CARDIAC CHEST PAIN 2 0.0006
376 RIB FRACTURE 13 0.0006
377 ENTERITIS 4 0.0006
378 ACUTE KIDNEY INJURY 95 0.0006
379 GASTROENTERITIS 9 0.0006
380 CEREBRAL INFARCTION 15 0.0006
381 RENAL CELL CARCINOMA 3 0.0006
382 CARDIAC FAILURE 49 0.0006
383 INCORRECT PRODUCT STORAGE 8 0.0006
384 PEPTIC ULCER 2 0.0006
385 SECOND PRIMARY MALIGNANCY 5 0.0006
386 RED BLOOD CELL COUNT DECREASED 17 0.0006
387 INFECTION 86 0.0006
388 DRUG TOLERANCE 3 0.0006
389 INFARCTION 4 0.0006
390 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
391 LEFT VENTRICULAR FAILURE 2 0.0006
392 DELIRIUM 20 0.0006
393 RESPIRATORY TRACT INFECTION 15 0.0006
394 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
395 THROMBOPHLEBITIS 2 0.0006
396 FIBRIN D DIMER INCREASED 2 0.0006
397 AORTIC VALVE STENOSIS 1 0.0006
398 RENAL DISORDER 26 0.0006
399 INTERSTITIAL LUNG DISEASE 27 0.0006
400 GINGIVITIS 3 0.0006
401 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
402 PULMONARY THROMBOSIS 6 0.0005
403 HYPERGLYCAEMIA 20 0.0005
404 ORAL DISORDER 4 0.0005
405 INTESTINAL ISCHAEMIA 3 0.0005
406 DIVERTICULITIS 15 0.0005
407 PRODUCT STORAGE ERROR 47 0.0005
408 THROMBOSIS 43 0.0005
409 BILE DUCT OBSTRUCTION 1 0.0005
410 ARTERIAL DISORDER 1 0.0005
411 CLAVICLE FRACTURE 2 0.0005
412 THYROID MASS 2 0.0005
413 HERPES VIRUS INFECTION 3 0.0005
414 ADRENAL DISORDER 1 0.0005
415 OESOPHAGEAL ULCER 2 0.0005
416 LIVER DISORDER 23 0.0005
417 HAEMOLYSIS 4 0.0005
418 ATELECTASIS 5 0.0005
419 ARTERIAL THROMBOSIS 1 0.0005
420 SINUS BRADYCARDIA 5 0.0005
421 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
422 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
423 ALCOHOL INTERACTION 1 0.0005
424 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
425 THROMBOTIC MICROANGIOPATHY 5 0.0005
426 SPINAL PAIN 6 0.0005
427 CHILLS 60 0.0005
428 VENOUS THROMBOSIS 2 0.0005
429 CATARACT 30 0.0005
430 HYPOMAGNESAEMIA 7 0.0005
431 ANORECTAL DISORDER 1 0.0005
432 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
433 C-REACTIVE PROTEIN INCREASED 18 0.0005
434 HEPATOTOXICITY 11 0.0005
435 NEURALGIA 12 0.0005
436 BONE MARROW FAILURE 10 0.0005
437 PERIPHERAL ISCHAEMIA 2 0.0005
438 CARDIOGENIC SHOCK 7 0.0005
439 BRONCHITIS 36 0.0005
440 HYPERBILIRUBINAEMIA 5 0.0005
441 THYROID FUNCTION TEST ABNORMAL 2 0.0005
442 DEHYDRATION 64 0.0005
443 BUNDLE BRANCH BLOCK LEFT 2 0.0005
444 ANAEMIA MACROCYTIC 1 0.0005
445 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
446 TENSION HEADACHE 2 0.0005
447 HYPOAESTHESIA ORAL 7 0.0005
448 BLOOD MAGNESIUM DECREASED 4 0.0005
449 BONE CANCER 2 0.0005
450 SKIN LACERATION 5 0.0005
451 INFLUENZA 51 0.0005
452 IMMUNE SYSTEM DISORDER 6 0.0005
453 HYPOKALAEMIA 21 0.0005
454 RENAL FAILURE 60 0.0005
455 DRUG ERUPTION 8 0.0005
456 CARDIOTOXICITY 4 0.0004
457 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
458 ENCEPHALOPATHY 11 0.0004
459 ADENOCARCINOMA 1 0.0004
460 EAR DISORDER 2 0.0004
461 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
462 PNEUMONIA BACTERIAL 4 0.0004
463 ENCEPHALITIS 3 0.0004
464 COVID-19 76 0.0004
465 LOCALISED OEDEMA 2 0.0004
466 LARGE INTESTINE PERFORATION 3 0.0004
467 ARTHRITIS INFECTIVE 2 0.0004
468 RENAL FUNCTION TEST ABNORMAL 2 0.0004
469 DEMENTIA 12 0.0004
470 PERFORMANCE STATUS DECREASED 2 0.0004
471 APPENDICITIS 4 0.0004
472 SPLENOMEGALY 5 0.0004
473 TIBIA FRACTURE 2 0.0004
474 SEASONAL ALLERGY 6 0.0004
475 SPINAL COLUMN STENOSIS 2 0.0004
476 SKIN ABRASION 2 0.0004
477 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
478 CARDIAC TAMPONADE 2 0.0004
479 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
480 SUBDURAL HAEMATOMA 6 0.0004
481 TUMOUR MARKER INCREASED 2 0.0004
482 CANDIDA INFECTION 7 0.0004
483 ACUTE MYOCARDIAL INFARCTION 12 0.0004
484 TOOTH DISORDER 9 0.0004
485 CONSTIPATION 88 0.0004
486 HAEMOGLOBIN DECREASED 41 0.0004
487 APPENDICITIS PERFORATED 1 0.0004
488 PETIT MAL EPILEPSY 2 0.0004
489 PERITONITIS 8 0.0004
490 PELVIC PAIN 7 0.0004
491 BONE DISORDER 7 0.0004
492 HERPES ZOSTER 22 0.0004
493 MULTIPLE ALLERGIES 3 0.0004
494 WEIGHT FLUCTUATION 4 0.0004
495 AFFECTIVE DISORDER 3 0.0004
496 SYNCOPE 38 0.0004
497 PNEUMOTHORAX 6 0.0004
498 GINGIVAL PAIN 3 0.0004
499 DYSGEUSIA 28 0.0004
500 ALCOHOL POISONING 1 0.0004
501 RHINITIS 3 0.0004
502 MUSCLE DISORDER 3 0.0004
503 HYPOXIA 13 0.0004
504 DECUBITUS ULCER 3 0.0004
505 MELAENA 8 0.0004
506 PROSTATIC DISORDER 2 0.0004
507 HYPERKERATOSIS 2 0.0004
508 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
509 PNEUMONIA ASPIRATION 9 0.0004
510 COAGULOPATHY 6 0.0004
511 HYPERTENSIVE CRISIS 4 0.0004
512 STREPTOCOCCAL INFECTION 2 0.0004
513 APHONIA 5 0.0004
514 DIARRHOEA 231 0.0004
515 MASS 5 0.0004
516 ANGIOPATHY 2 0.0004
517 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
518 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
519 EYE INFECTION 4 0.0004
520 REBOUND EFFECT 4 0.0004
521 PERONEAL NERVE PALSY 2 0.0004
522 NEUROLOGICAL SYMPTOM 2 0.0003
523 NEOPLASM 4 0.0003
524 MYOPATHY 3 0.0003
525 PYELONEPHRITIS 3 0.0003
526 DEATH 298 0.0003
527 DYSPNOEA EXERTIONAL 13 0.0003
528 ADENOVIRUS INFECTION 1 0.0003
529 RESPIRATORY FAILURE 25 0.0003
530 EOSINOPHILIA 6 0.0003
531 BLOOD CALCIUM INCREASED 3 0.0003
532 BRADYCARDIA 18 0.0003
533 CARDIOMYOPATHY 5 0.0003
534 ARRHYTHMIA 16 0.0003
535 FACIAL PAIN 3 0.0003
536 PULMONARY HYPERTENSION 7 0.0003
537 CARDIAC PACEMAKER INSERTION 2 0.0003
538 IMMUNODEFICIENCY 5 0.0003
539 GASTROINTESTINAL INFECTION 3 0.0003
540 LEUKOCYTOSIS 6 0.0003
541 DECREASED APPETITE 77 0.0003
542 OSTEOMYELITIS 6 0.0003
543 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
544 URINARY RETENTION 11 0.0003
545 DERMATITIS ACNEIFORM 2 0.0003
546 BRAIN NEOPLASM 3 0.0003
547 INCREASED TENDENCY TO BRUISE 3 0.0003
548 SKIN CANCER 7 0.0003
549 BONE PAIN 19 0.0003
550 GENERALISED OEDEMA 4 0.0003
551 ERYTHEMA MULTIFORME 3 0.0003
552 BACTERIAL INFECTION 6 0.0003
553 INFUSION SITE EXTRAVASATION 2 0.0003
554 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
555 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
556 BLOOD SODIUM DECREASED 6 0.0003
557 LEUKAEMIA 3 0.0003
558 MULTIPLE INJURIES 2 0.0003
559 HAEMATOTOXICITY 3 0.0003
560 FEELING JITTERY 6 0.0003
561 CYSTITIS 10 0.0003
562 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
563 GASTROINTESTINAL DISORDER 28 0.0003
564 HYPOTENSION 62 0.0003
565 CEREBRAL HAEMORRHAGE 11 0.0003
566 BLOOD CREATININE INCREASED 20 0.0003
567 RENAL TUBULAR NECROSIS 3 0.0003
568 ORAL CANDIDIASIS 4 0.0003
569 FATIGUE 236 0.0003
570 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
571 BLADDER DISORDER 3 0.0003
572 MUSCLE SPASMS 55 0.0003
573 SPINAL FRACTURE 6 0.0003
574 HEPATIC FAILURE 9 0.0003
575 RENAL IMPAIRMENT 25 0.0003
576 TASTE DISORDER 6 0.0003
577 OEDEMA PERIPHERAL 36 0.0003
578 HEMIPARESIS 5 0.0003
579 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
580 HEPATIC FUNCTION ABNORMAL 11 0.0003
581 TOOTH ABSCESS 3 0.0003
582 SLUGGISHNESS 3 0.0003
583 BLOOD TESTOSTERONE DECREASED 2 0.0003
584 APLASIA PURE RED CELL 1 0.0003
585 COLITIS 11 0.0003
586 DRUG INTOLERANCE 28 0.0003
587 DROOLING 2 0.0003
588 MULTI-ORGAN FAILURE 5 0.0003
589 VENTRICULAR EXTRASYSTOLES 3 0.0003
590 ORTHOSTATIC HYPOTENSION 5 0.0003
591 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
592 NEUROTOXICITY 5 0.0003
593 FULL BLOOD COUNT ABNORMAL 3 0.0003
594 URINARY TRACT INFECTION 48 0.0003
595 HIP FRACTURE 9 0.0003
596 GOUT 5 0.0003
597 CARDIAC DISORDER 26 0.0003
598 APPARENT DEATH 1 0.0003
599 GASTROENTERITIS VIRAL 5 0.0003
600 LIVER FUNCTION TEST ABNORMAL 8 0.0003
601 GASTROINTESTINAL PAIN 3 0.0003
602 DENTAL CARIES 3 0.0003
603 ALCOHOL USE 1 0.0003
604 AMYLASE INCREASED 1 0.0003
605 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
606 VENTRICULAR FIBRILLATION 3 0.0003
607 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
608 PULMONARY OEDEMA 12 0.0003
609 SKIN INFECTION 3 0.0003
610 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
611 HYPONATRAEMIA 15 0.0003
612 BLOOD POTASSIUM DECREASED 8 0.0003
613 MITRAL VALVE INCOMPETENCE 3 0.0003
614 MYOCARDIAL ISCHAEMIA 3 0.0003
615 TROPONIN INCREASED 2 0.0003
616 MYOCARDITIS 3 0.0003
617 GLAUCOMA 5 0.0003
618 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
619 BLOOD BILIRUBIN INCREASED 7 0.0003
620 NEOPLASM PROGRESSION 9 0.0003
621 ATRIOVENTRICULAR BLOCK 2 0.0003
622 PRESCRIBED OVERDOSE 5 0.0003
623 BACK PAIN 60 0.0003
624 EJECTION FRACTION DECREASED 4 0.0003
625 BLOOD IRON DECREASED 3 0.0003
626 SINUS DISORDER 5 0.0003
627 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
628 RENAL CYST 2 0.0003
629 TRICUSPID VALVE INCOMPETENCE 2 0.0003
630 PRESCRIBED UNDERDOSE 5 0.0003
631 BLOOD DISORDER 2 0.0002
632 DIABETES MELLITUS 19 0.0002
633 CARDIAC FAILURE CONGESTIVE 20 0.0002
634 NIGHT SWEATS 8 0.0002
635 TACHYCARDIA 22 0.0002
636 RHINORRHOEA 16 0.0002
637 ASTHENIA 93 0.0002
638 STOMATITIS 15 0.0002
639 FALL 82 0.0002
640 ARTHRITIS BACTERIAL 1 0.0002
641 MULTIPLE FRACTURES 4 0.0002
642 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
643 PHARYNGITIS 3 0.0002
644 EOSINOPHIL COUNT INCREASED 2 0.0002
645 PERICARDITIS 4 0.0002
646 UNEVALUABLE EVENT 18 0.0002
647 CARDIOVASCULAR DISORDER 6 0.0002
648 CIRCULATORY COLLAPSE 4 0.0002
649 ABSCESS LIMB 1 0.0002
650 RESPIRATORY DISORDER 7 0.0002
651 INSOMNIA 62 0.0002
652 RASH 101 0.0002
653 HAEMATOMA 6 0.0002
654 MUSCLE STRAIN 2 0.0002
655 PLEURAL EFFUSION 14 0.0002
656 TOOTH INFECTION 3 0.0002
657 ABDOMINAL ABSCESS 1 0.0002
658 HEAD DISCOMFORT 4 0.0002
659 NERVOUS SYSTEM DISORDER 7 0.0002
660 GALLBLADDER DISORDER 4 0.0002
661 MYOSITIS 2 0.0002
662 TACHYPNOEA 3 0.0002
663 GASTROINTESTINAL CARCINOMA 2 0.0002
664 END STAGE RENAL DISEASE 4 0.0002
665 ABDOMINAL HERNIA 1 0.0002
666 CARDIAC ARREST 18 0.0002
667 TREATMENT FAILURE 18 0.0002
668 FLUID RETENTION 11 0.0002
669 MENTAL STATUS CHANGES 6 0.0002
670 PRODUCT DISTRIBUTION ISSUE 2 0.0002
671 HEPATIC ENCEPHALOPATHY 2 0.0002
672 SKIN EXFOLIATION 18 0.0002
673 SPINAL DISORDER 2 0.0002
674 VIRAL INFECTION 7 0.0002
675 MUSCULOSKELETAL PAIN 11 0.0002
676 SKIN DISORDER 7 0.0002
677 HYPOACUSIS 9 0.0002
678 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
679 PULMONARY FIBROSIS 4 0.0002
680 LOCALISED INFECTION 5 0.0002
681 NASOPHARYNGITIS 38 0.0002
682 EAR PAIN 4 0.0002
683 DYSPHONIA 12 0.0002
684 LUNG DISORDER 10 0.0002
685 HEPATOMEGALY 2 0.0002
686 VITREOUS FLOATERS 2 0.0002
687 BODY TEMPERATURE DECREASED 2 0.0002
688 HOSPICE CARE 2 0.0002
689 MUSCULAR WEAKNESS 23 0.0002
690 TREATMENT NONCOMPLIANCE 11 0.0002
691 UPPER LIMB FRACTURE 4 0.0002
692 ADVERSE DRUG REACTION 18 0.0002
693 ANAPHYLACTIC REACTION 11 0.0002
694 TOXIC SKIN ERUPTION 2 0.0002
695 BLOOD COUNT ABNORMAL 3 0.0002
696 GASTRIC CANCER 5 0.0002
697 EYELID PTOSIS 2 0.0002
698 HEPATITIS 5 0.0002
699 NEUTROPHIL COUNT INCREASED 2 0.0002
700 DRUG RESISTANCE 5 0.0002
701 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
702 SKIN ULCER 5 0.0002
703 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
704 JOINT DISLOCATION 2 0.0002
705 RENAL FAILURE ACUTE 8 0.0002
706 BREAST CANCER METASTATIC 2 0.0002
707 INTESTINAL OBSTRUCTION 7 0.0002
708 LACTIC ACIDOSIS 6 0.0002
709 BEHAVIOUR DISORDER 1 0.0002
710 BACK DISORDER 3 0.0002
711 LIMB INJURY 5 0.0002
712 ASPIRATION 2 0.0002
713 ASTHENOPIA 1 0.0002
714 ARTHROPATHY 10 0.0002
715 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
716 MALNUTRITION 2 0.0002
717 BLOOD CALCIUM DECREASED 2 0.0002
718 STATUS EPILEPTICUS 2 0.0002
719 CONTUSION 17 0.0002
720 PAIN IN JAW 5 0.0002
721 HYPOAESTHESIA 26 0.0002
722 BALANCE DISORDER 15 0.0002
723 POST PROCEDURAL HAEMORRHAGE 2 0.0002
724 VASCULITIS 2 0.0002
725 HYPERKALAEMIA 6 0.0002
726 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
727 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
728 ATAXIA 2 0.0002
729 DISEASE RECURRENCE 8 0.0002
730 MACULAR DEGENERATION 2 0.0002
731 WRIST FRACTURE 2 0.0002
732 SINUSITIS 17 0.0002
733 CARDIOMEGALY 2 0.0002
734 SMALL INTESTINAL OBSTRUCTION 2 0.0002
735 BLOOD GLUCOSE ABNORMAL 3 0.0002
736 OFF LABEL USE 142 0.0002
737 LIMB DISCOMFORT 5 0.0002
738 AGRANULOCYTOSIS 3 0.0002
739 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
740 TOOTH EXTRACTION 2 0.0002
741 AGEUSIA 4 0.0002
742 GASTRIC ULCER 3 0.0002
743 MUSCULOSKELETAL DISORDER 3 0.0002
744 HYPOTHYROIDISM 5 0.0002
745 ROTATOR CUFF SYNDROME 2 0.0002
746 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
747 HYPERHIDROSIS 20 0.0002
748 DRUG INEFFECTIVE 204 0.0002
749 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
750 ANGINA UNSTABLE 1 0.0002
751 MEMORY IMPAIRMENT 21 0.0002
752 TINNITUS 7 0.0002
753 IMPAIRED HEALING 5 0.0002
754 OSTEONECROSIS 5 0.0002
755 PULMONARY CONGESTION 2 0.0002
756 STAPHYLOCOCCAL INFECTION 5 0.0002
757 HAEMATOCRIT DECREASED 3 0.0002
758 EAR INFECTION 4 0.0002
759 COUGH 42 0.0001
760 MYOCARDIAL INFARCTION 26 0.0001
761 THERAPEUTIC RESPONSE DECREASED 9 0.0001
762 OEDEMA 8 0.0001
763 DYSPNOEA 83 0.0001
764 HAEMATURIA 5 0.0001
765 LUNG NEOPLASM MALIGNANT 6 0.0001
766 MALAISE 64 0.0001
767 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
768 GASTRIC DISORDER 5 0.0001
769 HYPOGLYCAEMIA 7 0.0001
770 WEIGHT DECREASED 40 0.0001
771 HEART RATE DECREASED 5 0.0001
772 MOUTH ULCERATION 3 0.0001
773 BLOOD TEST ABNORMAL 2 0.0001
774 TOXICITY TO VARIOUS AGENTS 24 0.0001
775 OSTEOARTHRITIS 6 0.0001
776 FLATULENCE 8 0.0001
777 DIALYSIS 2 0.0001
778 SINUS TACHYCARDIA 2 0.0001
779 CHEST PAIN 26 0.0001
780 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
781 IRRITABLE BOWEL SYNDROME 3 0.0001
782 LIVER FUNCTION TEST INCREASED 3 0.0001
783 RECTAL HAEMORRHAGE 6 0.0001
784 ANGINA PECTORIS 4 0.0001
785 HYPERSOMNIA 4 0.0001
786 NAUSEA 110 0.0001
787 PARAESTHESIA ORAL 2 0.0001
788 TREMOR 23 0.0001
789 VOMITING 65 0.0001
790 ANOSMIA 2 0.0001
791 HYPOKINESIA 2 0.0001
792 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
793 VISUAL IMPAIRMENT 17 0.0001
794 PROSTATE CANCER 11 0.0001
795 RESTLESSNESS 5 0.0001
796 PERIPHERAL SWELLING 21 0.0001
797 ILLNESS 14 0.0001
798 INFLAMMATION 7 0.0001
799 URINARY INCONTINENCE 4 0.0001
800 SKIN HAEMORRHAGE 2 0.0001
801 ARTHROPOD BITE 1 0.0001
802 SNEEZING 3 0.0001
803 EPISTAXIS 10 0.0001
804 PANCREATITIS ACUTE 3 0.0001
805 ABDOMINAL PAIN 31 0.0001
806 DIZZINESS 66 0.0001
807 HYPERTENSION 28 0.0001
808 HEPATIC ENZYME INCREASED 9 0.0001
809 AORTIC ANEURYSM 1 0.0001
810 ACIDOSIS 1 0.0001
811 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
812 CONFUSIONAL STATE 21 0.0001
813 MUSCULOSKELETAL CHEST PAIN 2 0.0001
814 TENDONITIS 2 0.0001
815 COGNITIVE DISORDER 6 0.0001
816 DRUG-INDUCED LIVER INJURY 4 0.0001
817 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
818 HEPATIC CANCER 3 0.0001
819 PRESYNCOPE 3 0.0001
820 BLINDNESS 5 0.0001
821 ABNORMAL FAECES 1 0.0001
822 CHOLELITHIASIS 4 0.0001
823 LETHARGY 7 0.0001
824 EYE DISORDER 4 0.0001
825 VENTRICULAR TACHYCARDIA 2 0.0001
826 FACE OEDEMA 2 0.0001
827 ILL-DEFINED DISORDER 7 0.0001
828 SLEEP DISORDER 8 0.0001
829 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
830 THIRST 2 0.0001
831 DYSPEPSIA 11 0.0001
832 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
833 ANAL INCONTINENCE 1 0.0001
834 DRY MOUTH 9 0.0001
835 SYNOVITIS 2 0.0001
836 RASH PRURITIC 6 0.0001
837 HOSPITALISATION 17 0.0001
838 SKIN LESION 3 0.0001
839 RESPIRATORY DISTRESS 3 0.0001
840 DYSURIA 4 0.0001
841 OROPHARYNGEAL PAIN 10 0.0001
842 SWELLING 10 0.0001
843 ABDOMINAL DISTENSION 11 0.0001
844 BLOOD PRESSURE DECREASED 7 0.0001
845 CHOLESTASIS 2 0.0001
846 POST PROCEDURAL COMPLICATION 2 0.0001
847 LOWER LIMB FRACTURE 2 0.0001
848 AFFECT LABILITY 1 0.0001
849 PANCREATIC CARCINOMA 3 0.0001
850 ORAL HERPES 2 0.0001
851 DRY EYE 5 0.0001
852 MYALGIA 17 0.0001
853 APHASIA 3 0.0001
854 GAIT DISTURBANCE 19 0.0001
855 INTENTIONAL SELF-INJURY 2 0.0001
856 FEEDING DISORDER 2 0.0001
857 VERTIGO 6 0.0001
858 DISCOMFORT 6 0.0001
859 DRUG ADMINISTRATION ERROR 3 0.0001
860 ERYTHEMA 20 0.0001
861 HAEMORRHAGE 10 0.0001
862 VISION BLURRED 13 0.0001
863 METABOLIC ACIDOSIS 3 0.0001
864 RETCHING 2 0.0001
865 JOINT INJURY 2 0.0001
866 POOR QUALITY SLEEP 2 0.0001
867 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
868 ABDOMINAL PAIN UPPER 19 0.0001
869 FAECES DISCOLOURED 2 0.0001
870 AMNESIA 6 0.0001
871 PRODUCT DOSE OMISSION 6 0.0001
872 PRODUCT PRESCRIBING ISSUE 2 0.0001
873 PAIN IN EXTREMITY 27 0.0001
874 ARTHRALGIA 38 0.0001
875 GAIT INABILITY 3 0.0001
876 ABDOMINAL DISCOMFORT 15 0.0001
877 THROAT IRRITATION 4 0.0001
878 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
879 CHROMATURIA 2 0.0001
880 HEART RATE IRREGULAR 2 0.0001
881 CHEST DISCOMFORT 9 0.0001
882 NEPHROLITHIASIS 4 0.0001
883 SHOCK 2 0.0001
884 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
885 SEIZURE 10 0.0001
886 PERICARDIAL EFFUSION 2 0.0001
887 RASH MACULAR 3 0.0001
888 INFLUENZA LIKE ILLNESS 7 0.0001
889 BLOOD PRESSURE INCREASED 13 0.0001
890 WEIGHT INCREASED 19 0.0001
891 DIABETIC KETOACIDOSIS 2 0.0001
892 ASTHMA 9 0.0001
893 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
894 ABDOMINAL PAIN LOWER 2 0.0001
895 CHRONIC KIDNEY DISEASE 6 0.0001
896 THERAPY CESSATION 4 0.0001
897 RASH GENERALISED 2 0.0001
898 DIPLOPIA 2 0.0001
899 PALPITATIONS 9 0.0001
900 SWELLING FACE 5 0.0001
901 PAIN 47 0.0001
902 DEAFNESS 2 0.0001
903 SEDATION 2 0.0001
904 SPEECH DISORDER 4 0.0001
905 NEOPLASM MALIGNANT 5 0.0001
906 JAUNDICE 2 0.0001
907 DYSKINESIA 3 0.0001
908 DYSPHAGIA 7 0.0001
909 RESPIRATORY ARREST 2 0.0001
910 WOUND 2 0.0001
911 BLISTER 4 0.0001
912 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
913 PARAESTHESIA 11 0.0001
914 SOMNOLENCE 14 0.0001
915 AGITATION 5 0.0001
916 NASAL CONGESTION 4 0.0001
917 PRURITUS 26 0.0001
918 IRRITABILITY 4 0.0001
919 ALOPECIA 13 0.0001
920 CORONARY ARTERY DISEASE 2 0.0001
921 BLOOD CHOLESTEROL INCREASED 3 0.0001
922 BLOOD GLUCOSE INCREASED 12 0.0001
923 HEAD INJURY 2 0.0001
924 COMA 3 0.0001
925 PRODUCTIVE COUGH 3 0.0001
926 LOSS OF CONSCIOUSNESS 8 0.0001
927 MOVEMENT DISORDER 2 0.0001
928 HEART RATE INCREASED 6 0.0001
929 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
930 VISUAL ACUITY REDUCED 2 0.0001
931 FUNGAL INFECTION 2 0.0001
932 DRY SKIN 8 0.0001
933 CEREBROVASCULAR ACCIDENT 10 0.0001
934 FLUSHING 6 0.0001
935 JOINT SWELLING 7 0.0001
936 MUSCULOSKELETAL STIFFNESS 5 0.0001
937 PANCREATITIS 3 0.0001
938 DEPRESSED MOOD 3 0.0001
939 LYMPHADENOPATHY 2 0.0001
940 THERAPY INTERRUPTED 4 0.0001
941 NO ADVERSE EVENT 10 0.0001
942 CRYING 2 0.0001
943 FEELING ABNORMAL 13 0.0001
944 HYPERSENSITIVITY 10 0.0001
945 EYE SWELLING 2 0.0001
946 PRODUCT USE ISSUE 10 0.0001
947 CONDITION AGGRAVATED 16 0.0001
948 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
949 PRODUCT DOSE OMISSION ISSUE 15 0.0001
950 BLADDER CANCER 3 0.0001
951 ARTHRITIS 4 0.0001
952 WHEEZING 3 0.0001
953 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
954 DISORIENTATION 2 0.0001
955 HEADACHE 31 0.0000
956 OSTEOPOROSIS 2 0.0000
957 DEPRESSION 11 0.0000
958 POLLAKIURIA 2 0.0000
959 MENTAL DISORDER 2 0.0000
960 INJECTION SITE REACTION 3 0.0000
961 SKIN DISCOLOURATION 2 0.0000
962 INJURY 3 0.0000
963 DRUG DOSE OMISSION 7 0.0000
964 SKIN BURNING SENSATION 3 0.0000
965 RASH ERYTHEMATOUS 2 0.0000
966 MULTIPLE SCLEROSIS 2 0.0000
967 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
968 ABASIA 1 0.0000
969 HOT FLUSH 3 0.0000
970 ANAPHYLACTIC SHOCK 1 0.0000
971 NERVOUSNESS 2 0.0000
972 ECZEMA 2 0.0000
973 DRUG EFFECT DECREASED 2 0.0000
974 DISTURBANCE IN ATTENTION 2 0.0000
975 NECK PAIN 2 0.0000
976 SURGERY 2 0.0000
977 FEELING HOT 2 0.0000
978 BREAST CANCER 3 0.0000
979 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
980 BURNING SENSATION 2 0.0000
981 UNDERDOSE 2 0.0000
982 ACCIDENTAL OVERDOSE 1 0.0000
983 HALLUCINATION 2 0.0000
984 ABNORMAL BEHAVIOUR 1 0.0000
985 ANXIETY 7 0.0000
986 ANGIOEDEMA 1 0.0000
987 INCORRECT DOSE ADMINISTERED 5 0.0000
988 AGGRESSION 1 0.0000
989 DRUG INTERACTION 3 0.0000
990 OVERDOSE 4 0.0000
991 URTICARIA 2 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
993 INJECTION SITE PAIN 3 0.0000